Forecast: Cervix Uteri Malignant Neoplasms Mortality in Switzerland

The cervical cancer mortality rate in Switzerland shows a declining trend. From 2024's rate of 1.4 deaths per hundred thousand women, the forecasted rate decreases sequentially to 1.1 by 2028. Compared to 2023, the mortality rate stood at 1.5, indicating significant annual improvements. The year-on-year variation shows -7.14% from 2023 to 2024, -7.69% from 2024 to 2025, a stable rate from 2025 to 2026, -7.69% from 2026 to 2027, and -9.09% from 2027 to 2028. The compound annual growth rate (CAGR) over these five years averages approximately -6.23% annually.

Future trends to watch for:

- Innovations in vaccination and screening programs could further decrease mortality rates.

- Advances in treatment options and early detection methods may also play a significant role in reducing mortality.

- Health awareness campaigns and improved access to healthcare might enhance preventive measures, contributing to a continued downward trend.

Top Countries about HPV Testing